550
A. L. S. Thompson et al.
PAPER
MS (EI): m/z (%) = 256 (10), 254 (9), 199 (97), 197 (100), 171 (21),
(3) Thompson, A. L. S., unpublished work..
169 (21).
(4) (a) Dominianni, S. J.; Ryan, C. W.; De Armitt, C. W. J. Org.
Chem. 1977, 42, 344. (b) Huffman, J. W.; Joyner, H. H.;
Lee, M. D.; Jordan, R. D.; Pennington, W. T. J. Org. Chem.
1991, 56, 2081.
HRMS: m/z calcd for C13H19Br: 254.0670; found: 254.0664.
1-Bromo-4-(1,1-dimethylhexyl)benzene
(5) (a) Bay, E.; Bak, D. A.; Timony, P. E.; Leone-Bay, A. J.
Org. Chem. 1990, 55, 3415. (b) Bestman, H. J.; Schnabel,
K. H. Justus Liebigs Ann. Chem. 1966, 698, 106. (c) Wiley,
G. A.; Hershkowitz, R. L.; Rein, B. M.; Chung, B. C. J. Am.
Chem. Soc. 1964, 86, 964. (d) Albert, A.; Clarke, J. J. Chem.
Soc. 1964, 1666. (e) Park, J. D.; Rosser, R. W.; Lacher, J. R.
J. Org. Chem. 1962, 27, 1462. (f) Cramer, R.; Coffman, D.
D. J. Org. Chem. 1961, 26, 4164. (g) Price, C. C.; Roberts,
E. M. Org. Synth. Coll. Vol III; Wiley: New York, 1955,
272. (h) Bendich, A.; Russell, P. J.; Fox, J. J. J. Am. Chem.
Soc. 1954, 76, 6073. (i) Surrey, A. R.; Cutler, R. A. J. Am.
Chem. Soc. 1954, 76, 1109. (j) Baddiley, J.; Topham, A. J.
Chem. Soc. 1944, 678.
Oil.
IR (CHCl3): 3090, 3072, 3048, 2965, 2932, 2862, 1496, 1480, 1395,
1370, 1117, 1094, 1081, 1005, 823, 720, 561 cm–1.
1H NMR (300 MHz, CDCl3): d = 0.82 (t, J = 6.9 Hz, 3 H), 0.95–1.10
(m, 2 H), 1.10–1.23 (m, 4 H), 1.25 (s, 6 H), 1.51–1.58 (m, 2 H), 7.17
(d, J = 8.6 Hz, 2 H), 7.39 (d, J = 8.6 Hz, 2 H).
13C NMR (75.5 MHz, CDCl3): d = 14.0, 22.5, 24.3, 28.8, 32.5, 37.5,
44.4, 119.1, 127.7, 131.0, 148.8.
MS (EI): m/z (%) = 270 (8), 268 (8), 199 (99), 197 (100), 171 (20),
169 (20).
HRMS: m/z calcd for C14H21Br: 268.0827; found: 268.0826.
(6) Murata, M.; Oyama, T.; Watanabe, W.; Masuda, Y. J. Org.
Chem. 2000, 65, 164.
(7) Kabalka, G. W.; Akula, M. R.; Zhang, J. Nucl. Med. Biol.
1-Bromo-4-(1,1-dimethylheptyl)benzene
Oil.
2002, 29, 841.
IR (CHCl3): 3093, 3077, 3060, 2969, 2928, 2860, 1489, 1468, 1396,
1104, 1093, 1085, 1008, 822, 732, 557 cm–1.
(8) Kabalka, G. W.; Sastry, K. A. R.; Sastry, U.; Somayaji, V.
Org. Prep. Proced. Int. 1982, 14, 359.
1H NMR (500 MHz, CDCl3): d = 0.84 (t, J = 6.9 Hz, 3 H), 0.97–1.08
(m, 2 H), 1.15–1.20 (m, 4 H), 1.20–1.24 (m, 2 H), 1.25 (s, 6 H),
1.53–1.58 (m, 2 H), 7.18 (d, J = 8.7 Hz, 2 H), 7.39 (d, J = 8.7 Hz, 2
H).
13C NMR (125.8 MHz, CDCl3): d = 14.1, 22.6, 24.6, 28.8, 30.0,
31.7, 37.5, 44.5, 119.1, 127.7, 131.0, 148.8.
(9) Pinacolboronates 6 could be converted to the corresponding
boronic acid using NaIO4 and NH4OAc. The boronic acids
were then converted to the aryl bromide under the conditions
described in ref.7 The overall yields for this procedure were
inferior to those developed subsequently.
(10) Nesmejanow, A. N.; Perewalowa, E. G.; Jurjewa, L. P.
Chem. Ber. 1960, 2729.
(11) For selected examples of experimental methods for the
preparation of trifluoromethanesulfonates, see: (a)Ritter,K.
Synthesis 1993, 735. (b) Stang, P. J.; Hanack, M.;
Subramanian, L. R. Synthesis 1982, 85. (c) Echavarren, A.
M.; Stille, J. K. J. Am. Chem. Soc. 1987, 109, 5478.
(d) Tilley, J. W.; Danho, W.; Lovey, K.; Wagner, R.;
Swistok, J.; Makofske, R.; Michalewsky, J.; Triscari, J.;
Nelson, D.; Weatherford, S. J. Med. Chem. 1991, 34, 1125.
(e) Rudisill, D. E.; Stille, J. K. J. Org. Chem. 1989, 54, 5856.
(12) Kaliakoudas, D.; Eugster, C. H.; Ruedi, P. Helv. Chim. Acta
1990, 73, 48.
MS (EI): m/z = 284 (7), 282 (7), 199 (98), 197 (100), 171 (17), 169
(18).
HRMS: m/z calcd for C15H23Br: 282.0983; found: 282.0988.
Acknowledgment
The work at Clemson University was supported by grants R01
DA03590 and K05 DA15340, both from the National Institute on
Drug Abuse. The work at the University of Tennessee was suppor-
ted by the U.S. Department of Energy and the Robert H. Cole Foun-
dation.
(13) (a) Harayama, T.; Nakatsuka, K.; Nishioka, H.; Murakami,
K.; Hayashida, N.; Ishii, H. Chem. Pharm. Bull. 1994, 42,
2170. (b) Mitteilung, K.; Reisch, J.; Rosenthal, B. H. W.
Monatsh. Chem. 1987, 118, 871.
References
(14) Sukman, E. L. U.S. Patent, 4264593, 1981; no spectroscopic
(1) Johnson, M. R.; Melvin, L. S. In Cannabinoids as
Therapeutic Agents; Mechoulam, R., Ed.; CRC Press: Boca
Raton, 1986, 121–145.
(2) Huffman, J. W.; Liddle, J.; Yu, S.; Aung, M. M.; Abood, M.
E.; Wiley, J. L.; Martin, B. R. Bioorg. Med. Chem. 1999, 7,
2095.
data are included in this patent.
(15) Barluenga, J.; Campos, P. J.; Gonzalez, J. M.; Asensio, G. J.
Chem. Soc, Perkin Trans. 1 1984, 2623.
Synthesis 2005, No. 4, 547–550 © Thieme Stuttgart · New York